• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纳米颗粒通过内皮细胞的小窝泵系统快速精准靶向肺部。

Rapid precision targeting of nanoparticles to lung via caveolae pumping system in endothelium.

作者信息

Nayak Tapas R, Chrastina Adrian, Valencia Jose, Cordova-Robles Oscar, Yedidsion Robert, Buss Tim, Cederstrom Brittany, Koziol Jim, Levin Michael D, Olenyuk Bogdan, Schnitzer Jan E

机构信息

Proteogenomics Research Institute for Systems Medicine, La Jolla, CA, USA.

Department of Chemistry, University of Utah, Salt Lake City, UT, USA.

出版信息

Nat Nanotechnol. 2025 Jan;20(1):144-155. doi: 10.1038/s41565-024-01786-z. Epub 2024 Oct 8.

DOI:10.1038/s41565-024-01786-z
PMID:39379614
Abstract

Modern medicine seeks precision targeting, imaging and therapy to maximize efficacy and avoid toxicities. Nanoparticles (NPs) have tremendous yet unmet clinical potential to carry and deliver imaging and therapeutic agents systemically with tissue precision. But their size contributes to rapid scavenging by the reticuloendothelial system and poor penetration of key endothelial cell (EC) barriers, limiting target tissue uptake, safety and efficacy. Here we discover the ability of the EC caveolae pumping system to outpace scavenging and deliver NPs rapidly and specifically into the lungs. Gold and dendritic NPs are conjugated to antibodies targeting caveolae of the lung microvascular endothelium. SPECT-CT imaging and biodistribution analyses reveal that rat lungs extract most of the intravenous dose within minutes to achieve precision lung imaging and targeting with high lung concentrations exceeding peak blood levels. These results reveal how much ECs can both limit and promote tissue penetration of NPs and the power and size-dependent limitations of the caveolae pumping system. This study provides a new retargeting paradigm for NPs to avoid reticuloendothelial system uptake and achieve rapid precision nanodelivery for future diagnostic and therapeutic applications.

摘要

现代医学追求精准靶向、成像和治疗,以实现疗效最大化并避免毒性。纳米颗粒(NPs)在全身携带和递送成像及治疗药物并实现组织精准性方面具有巨大但尚未满足的临床潜力。但其尺寸导致其被网状内皮系统快速清除,且难以穿透关键的内皮细胞(EC)屏障,从而限制了靶组织摄取、安全性和疗效。在此,我们发现内皮细胞小窝泵系统能够超越清除作用,将纳米颗粒快速且特异性地递送至肺部。金纳米颗粒和树枝状纳米颗粒与靶向肺微血管内皮细胞小窝的抗体偶联。单光子发射计算机断层扫描-计算机断层扫描(SPECT-CT)成像和生物分布分析显示,大鼠肺部在数分钟内摄取了大部分静脉注射剂量,从而实现了精准的肺部成像和靶向,肺部高浓度超过血药峰值水平。这些结果揭示了内皮细胞在多大程度上既能限制又能促进纳米颗粒的组织穿透,以及小窝泵系统的能力和尺寸依赖性限制。本研究为纳米颗粒提供了一种新的重新靶向范例,以避免网状内皮系统摄取,并实现快速精准的纳米递送,用于未来的诊断和治疗应用。

相似文献

1
Rapid precision targeting of nanoparticles to lung via caveolae pumping system in endothelium.纳米颗粒通过内皮细胞的小窝泵系统快速精准靶向肺部。
Nat Nanotechnol. 2025 Jan;20(1):144-155. doi: 10.1038/s41565-024-01786-z. Epub 2024 Oct 8.
2
Lung vascular targeting using antibody to aminopeptidase P: CT-SPECT imaging, biodistribution and pharmacokinetic analysis.使用氨肽酶P抗体进行肺血管靶向:CT-SPECT成像、生物分布及药代动力学分析。
J Vasc Res. 2010;47(6):531-43. doi: 10.1159/000313880. Epub 2010 Apr 30.
3
Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lung.对小窝泵浦靶向抗体在肺内皮细胞间快速且特异性地穿梭进行实时动态成像。
Nat Biotechnol. 2007 Mar;25(3):327-37. doi: 10.1038/nbt1292. Epub 2007 Mar 4.
4
In vivo proteomic imaging analysis of caveolae reveals pumping system to penetrate solid tumors.体内腔囊蛋白组学成像分析揭示了穿透实体瘤的泵送系统。
Nat Med. 2014 Sep;20(9):1062-8. doi: 10.1038/nm.3623. Epub 2014 Aug 17.
5
Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene delivery.靶向内皮细胞及其动态小窝进行体内组织特异性转胞吞作用:一种克服细胞屏障以实现药物和基因递送的途径。
Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):1996-2001. doi: 10.1073/pnas.251662398.
6
Targeting caveolae to pump bispecific antibody to TGF-β into diseased lungs enables ultra-low dose therapeutic efficacy.靶向质膜微囊泡将双特异性抗体 TGF-β 泵入病变肺部可实现超低剂量的治疗效果。
PLoS One. 2022 Nov 22;17(11):e0276462. doi: 10.1371/journal.pone.0276462. eCollection 2022.
7
Overcoming in vivo barriers to targeted nanodelivery.克服靶向纳米递药的体内障碍。
Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2011 Jul-Aug;3(4):421-37. doi: 10.1002/wnan.143. Epub 2011 Apr 27.
8
Engineering of caveolae-specific self-micellizing anticancer lipid nanoparticles to enhance the chemotherapeutic efficacy of oxaliplatin in colorectal cancer cells.工程化制备小窝特异性自微乳化抗癌脂质纳米粒以增强奥沙利铂对结肠癌细胞的化疗疗效。
Acta Biomater. 2016 Sep 15;42:220-231. doi: 10.1016/j.actbio.2016.07.006. Epub 2016 Jul 6.
9
LaPO4 nanoparticles doped with actinium-225 that partially sequester daughter radionuclides.镤-225 掺杂的磷灰石纳米颗粒,部分隔离子体放射性核素。
Bioconjug Chem. 2011 Apr 20;22(4):766-76. doi: 10.1021/bc100574f. Epub 2011 Mar 24.
10
In vivo imaging of 64Cu-labeled polymer nanoparticles targeted to the lung endothelium.靶向肺内皮细胞的64Cu标记聚合物纳米颗粒的体内成像。
J Nucl Med. 2008 Jan;49(1):103-11. doi: 10.2967/jnumed.107.045302. Epub 2007 Dec 12.

引用本文的文献

1
Research progress of nano-based drug delivery systems based on stimuli-responsive materials for the treatment of lung diseases.基于刺激响应材料的纳米药物递送系统治疗肺部疾病的研究进展
Front Bioeng Biotechnol. 2025 Jul 31;13:1644007. doi: 10.3389/fbioe.2025.1644007. eCollection 2025.
2
Clinical Scaleup of Humanized AnnA1 Antibody Yielded Unexpected High Reticuloendothelial (RES) Uptake in Mice.人源化AnnA1抗体的临床放大生产在小鼠中产生了意外的高网状内皮系统(RES)摄取。
Antibodies (Basel). 2025 Feb 6;14(1):14. doi: 10.3390/antib14010014.

本文引用的文献

1
Strategies for Delivering Nanoparticles across Tumor Blood Vessels.纳米颗粒穿越肿瘤血管的递送策略。
Adv Funct Mater. 2021 Feb 17;31(8). doi: 10.1002/adfm.202007363. Epub 2020 Nov 12.
2
Nanodrug delivery systems for metabolic chronic liver diseases: advances and perspectives.用于代谢性慢性肝病的纳米药物递送系统:进展与展望
Nanomedicine (Lond). 2023 Jan;18(1):67-84. doi: 10.2217/nnm-2022-0261. Epub 2023 Mar 10.
3
Targeting caveolae to pump bispecific antibody to TGF-β into diseased lungs enables ultra-low dose therapeutic efficacy.
靶向质膜微囊泡将双特异性抗体 TGF-β 泵入病变肺部可实现超低剂量的治疗效果。
PLoS One. 2022 Nov 22;17(11):e0276462. doi: 10.1371/journal.pone.0276462. eCollection 2022.
4
Nanotechnology in Drug Delivery for Liver Fibrosis.用于肝纤维化的药物递送中的纳米技术
Front Mol Biosci. 2022 Jan 11;8:804396. doi: 10.3389/fmolb.2021.804396. eCollection 2021.
5
Chemo-physical Strategies to Advance the Functionality of Targeted Nanomedicine: The Next Generation.化学物理策略推进靶向纳米医学的功能性:下一代。
J Am Chem Soc. 2021 Jan 20;143(2):538-559. doi: 10.1021/jacs.0c09029. Epub 2020 Dec 28.
6
Engineering precision nanoparticles for drug delivery.工程化精准纳米颗粒用于药物递送。
Nat Rev Drug Discov. 2021 Feb;20(2):101-124. doi: 10.1038/s41573-020-0090-8. Epub 2020 Dec 4.
7
What Went Wrong with Anticancer Nanomedicine Design and How to Make It Right.抗癌纳米药物设计出了什么问题以及如何纠正
ACS Nano. 2020 Oct 27;14(10):12281-12290. doi: 10.1021/acsnano.9b09713. Epub 2020 Oct 6.
8
A framework for designing delivery systems.设计传递系统的框架。
Nat Nanotechnol. 2020 Oct;15(10):819-829. doi: 10.1038/s41565-020-0759-5. Epub 2020 Sep 7.
9
Meta-Analysis of Nanoparticle Delivery to Tumors Using a Physiologically Based Pharmacokinetic Modeling and Simulation Approach.基于生理的药代动力学建模与模拟方法分析纳米颗粒向肿瘤的递送
ACS Nano. 2020 Mar 24;14(3):3075-3095. doi: 10.1021/acsnano.9b08142. Epub 2020 Mar 4.
10
Overcoming Physiological Barriers to Nanoparticle Delivery-Are We There Yet?克服纳米颗粒递送的生理障碍——我们做到了吗?
Front Bioeng Biotechnol. 2019 Dec 17;7:415. doi: 10.3389/fbioe.2019.00415. eCollection 2019.